Login / Signup

OPTIMA: An Open-Label, Non-comparative Pilot Trial of Inhaled Molgramostim in Pulmonary Nontuberculous Mycobacterial Infection.

Rachel M ThomsonMichael R LoebingerAndrew J BurkeLucy C MorganGrant W WatererCecilia Ganslandt
Published in: Annals of the American Thoracic Society (2023)
ClinicalTrials.gov No: NCT03421743.
Keyphrases
  • pulmonary hypertension
  • mycobacterium tuberculosis
  • cystic fibrosis